Dr Barry Palmer

Cardioendocrine Research Group, University of Otago, Christchurch

Barry joined the multi-disciplinary Christchurch Cardioendocrine Research Group in 2000. His current research interests are focused on the Genetics of Heart Disease; the main element being the role of genes from the X-chromosome in the development and progression of Cardiovascular Disease. Barry's previous research interests include the genetics of Sheep Meat Quality and Microbial Genetics.

More information on Barry's work.

Recent Publications

Jarvis, M.D., Palmer, B.R, Pilbrow A.P, Ellis,K.L., Frampton, C.M., Skelton L., Doughty, R.N., Whalley, G.A., Ellis,C.J., Yandle, T.G., Richards, A.M., and Cameron, V.A. (2009). Cyp1a1 mspi (t6235c) gene polymorphism predicts mortality in an acute coronary syndromes patient cohort. Clinical & Experimental Pharmacology & Physiology. In press.

Palmer, B.R, Devereaux , C.L., Dhamrait , S.S., Mocatta , T.J., Pilbrow A.P, Frampton, C.M., Skelton L., Yandle, T.G., Winterbourn, C.C., Richards, A.M., Montgomery, H.E. and Cameron, V.A. (2009). The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction. Cardiovascular Diabetology 2009, 8:31.

Littlejohn, M.D., Palmer, B. R. et al. Ile164 variant of beta 2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment. European Journal of Heart Failure 10, 55-59 (2008).

Palmer, B.R. et al. Genetics - Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. American Heart Journal 156, 752-758 (2008).

Palmer, B.R. et al. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. European Heart Journal 29, 2489-2496 (2008)